Eptifibatide: The evidence for its role in the management of acute coronary syndromes

INTRODUCTION: Acute coronary syndromes and non-Q-wave myocardial infarction are often initiated by platelet activation. Eptifibatide is a cyclic heptapeptide and is the third inhibitor of glycoprotein (Gp) IIb/IIIa that has found broad acceptance after the specific antibody abciximab and the nonpept...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Ibrahim, Khan, Shakeel O, Malhotra, Surender, Fischell, Tim
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2899786/
https://www.ncbi.nlm.nih.gov/pubmed/20694065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2899786/
https://www.ncbi.nlm.nih.gov/pubmed/20694065

Ejemplares similares